FINWIRES · TerminalLIVE
FINWIRES

TYO:4519

5 stories mentioning TYO:4519Updated 6d ago

Every FINWIRES story that references TYO:4519, newest first.

Asia

Chugai Pharmaceutical's H1 Profit Jumps 19%

Chugai Pharmaceutical (TYO:4519) posted a 19% year-over-year increase in net income in the first half to 231.7 billion yen from 194.4 billion yen a year earlier.Earnings per share were 140.82 yen compared with 118.12 yen a year earlier, according to a Tokyo Stock Exchange filing on Friday.Revenue rose 15% to 663.3 billion yen in the six months ended June 30 from 578.5 billion yen.The company declared an interim dividend of 66 yen per share, payable from Aug. 28.For the year ending Dec. 31, Chugai expects core net income of 485 billion yen, core EPS of 295.00 yen, and revenue of 1.345 trillion yen.

TYO:4519
Asia

Japan Shares Rebound as Tech Earnings Season Commences

Japanese shares rebounded when trading resumed after Monday's holiday, bucking broader regional declines, amid heightened tensions in the Middle East.The Nikkei 225 rose 402.9 points or 0.6% to open at 64,544.05.This week marks the start of megacap earnings, with Tesla and Alphabet reporting on Wednesday, followed by Microsoft, Meta, Apple, and Amazon next week, as investors demand clearer returns on massive AI spending.At home, Sumitomo Mitsui Financial Group (TYO:8316), Chugai Pharmaceutical (TYO:4519) and Shin-etsu Chemical (TYO:4063) are set to release earnings reports this week.

Nikkei 225TYO:4063TYO:4519TYO:8316
Research

Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen

Chugai Pharmaceutical (TYO:4519) has an average rating of overweight and mean price target of 10,240 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

TYO:4519
Asia

Keyence, Fanuc Shares Climb, Chugai Declines as Japan Stocks Mixed After Earnings

Japanese stocks that reported recent earnings traded mixed on Monday, with gains led by companies posting solid profit growth and shareholder returns, while one major drugmaker declined despite higher quarterly earnings.Keyence (TYO:6861) shares jumped 16% after reporting full-year results, with net income attributable to owners of parent rising 12% to 445.19 billion yen as revenue increased 10% to 1.169 trillion yen. The company raised its annual dividend to 550 yen per share from 350 yen.Fanuc (TYO:6954) shares also gained 16% after posting annual results, with net income attributable to owners of parent climbing 13% to 166.54 billion yen, while revenue rose 8% to 857.83 billion yen.The company expects full-year net income attributable to owners of the parent of 184.9 billion yen and revenue of 909.6 billion yen for the financial year ending March 31, 2027. It also raised its annual dividend to 107.09 yen per share from 94.39 yen.Meanwhile, Chugai Pharmaceutical (TYO:4519) fell 16% despite reporting stronger first-quarter earnings. Net income attributable to shareholders rose 19% to 115.42 billion yen as revenue increased 12% to 321.75 billion yen. The company expects full-year revenue of 1.345 trillion yen and core net income of 485 billion yen, with an annual dividend forecast of 132 yen per share.

Nikkei 225TYO:4519TYO:6861TYO:6954
Asia

Chugai Pharmaceutical's Q1 Income Rises 19%

Chugai Pharmaceutical's (TYO:4519) net income attributable to owners rose nearly 19% to 115.4 billion yen in the first quarter from 97.2 billion yen a year earlier.The pharmaceutical group's earnings per share increased to 70.13 yen from 59.08 yen a year ago, according to a Tokyo bourse filing on Friday.Revenue grew 12% to 321.7 billion yen for the three months ended March 31 from 288.5 billion yen in the prior year.For the full year ending Dec. 31, the company expects core net income of 485 billion yen, core EPS of 295 yen, and revenue of 1.345 trillion yen.

TYO:4519

Track with the FINWIRES app suite

FolioX
FolioX
Track TYO:4519 in your portfolio
WheelAI
WheelAI
Analyze TYO:4519 options with the wheel strategy
StockInsider
StockInsider
See market sentiment on TYO:4519